Related references
Note: Only part of the references are listed.Increased proportion of FoxP3+regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastoma
Elias J. Sayour et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Pharmacological Improvement and Preclinical Evaluation of Methotrexate-Loaded Lipid-Core Nanocapsules in a Glioblastoma Model
Fabricio Figueiro et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2015)
Adenosine A2A Receptors Intrinsically Regulate CD8+ T Cells in the Tumor Microenvironment
Caglar Cekic et al.
CANCER RESEARCH (2014)
Immunoregulatory activity of adenosine and its role in human cancer progression
Sylvia Muller-Haegele et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2014)
Glioblastoma cancer stem cells: Biomarker and therapeutic advances
Kelli B. Pointer et al.
NEUROCHEMISTRY INTERNATIONAL (2014)
Activation of adenosine A2A receptor reduces osteoclast formation via PKA- and ERK1/2-mediated suppression of NFκB nuclear translocation
Aranzazu Mediero et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
A review of therapeutic challenges and achievements of methotrexate delivery systems for treatment of cancer and rheumatoid arthritis
Samira Sadat Abolmaali et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Immune modulation of effector CD4+ and regulatory T cell function by sorafenib in patients with hepatocellular carcinoma
Roniel Cabrera et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
CD39 is highly involved in mediating the suppression activity of tumor-infiltrating CD8+ T regulatory lymphocytes
Alessia Parodi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Influence of anticancer agents on cell survival, proliferation, and CD4+CD25+Foxp3+ regulatory T cell-frequency in human peripheral-blood mononuclear cells activated by T cell-mitogen
Naoya Tohyama et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2013)
Resveratrol-Loaded Lipid-Core Nanocapsules Treatment Reduces In Vitro and In Vivo Glioma Growth
Fabricio Figueiro et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2013)
Synergy between the ectoenzymes CD39 and CD73 contributes to adenosinergic immunosuppression in human malignant gliomas
Shuo Xu et al.
NEURO-ONCOLOGY (2013)
Adenosine as an endogenous immunoregulator in cancer pathogenesis: where to go?
V. Kumar
PURINERGIC SIGNALLING (2013)
Curcumin inhibits suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro
Guang-ju Zhao et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2012)
The Adenosine A3 Receptor Agonist Cl-IB-MECA Induces Cell Death Through Ca2+/ROS-Dependent Down Regulation of ERK and Akt in A172 Human Glioma Cells
Thae Hyun Kim et al.
NEUROCHEMICAL RESEARCH (2012)
CD73 Expression as a Potential Marker of Good Prognosis in Breast Carcinoma
Anna Supernat et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2012)
Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity
Sebastian F. M. Haeusler et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
High dose methotrexate for pediatric high grade glioma: results of the HIT-GBM-D Pilot study
Johannes E. Wolff et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Inhibitors of Glioma Growth that Reveal the Tumour to the Immune System
Manuel Nieto-Sampedro et al.
CLINICAL MEDICINE INSIGHTS-ONCOLOGY (2011)
Exciting New Advances in Neuro-Oncology The Avenue to a Cure for Malignant Glioma
Erwin G. Van Meir et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Mechanisms of Local Immunoresistance in Glioma
Emilia Albesiano et al.
NEUROSURGERY CLINICS OF NORTH AMERICA (2010)
Extracellular adenosine triphosphate and adenosine in cancer
J. Stagg et al.
ONCOGENE (2010)
Increased Ectonucleotidase Expression and Activity in Regulatory T Cells of Patients with Head and Neck Cancer
Magis Mandapathil et al.
CLINICAL CANCER RESEARCH (2009)
Isolation of functional human regulatory T cells (Treg) from the peripheral blood based on the CD39 expression
Magis Mandapathil et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2009)
T regulatory cells: hypoxia-adenosinergic suppression and re-direction of the immune response
Michail V. Sitkovsky
TRENDS IN IMMUNOLOGY (2009)
Cooperation of adenosine and prostaglandin E2 (PGE2) in amplification of cAMP-PKA signaling and immunosuppression
Yunyun Su et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Regulatory T-cell inhibition versus depletion: the right choice in cancer immunotherapy
Mario P. Colombo et al.
NATURE REVIEWS CANCER (2007)
Indomethacin stimulates activity and expression of ecto-5′nucleotidase/CD73 in glioma cell lines
Andressa Bemardi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
The antiinflammatory mechanism ot methotrexate depends on extracellular conversion of adenine nucleotides to adenosine by ecto-5′-nucleotidase -: Findings in a study of ecto-5′-nucleotidase gene-deficient mice
M. Carmen Montesinos et al.
ARTHRITIS AND RHEUMATISM (2007)
Metronomic cyclophosphamide regimen selectively depletes CD4+ CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients
Francois Ghiringhelli et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Altered extracellular ATP, ADP and AMP catabolism in glioma cell lines
MR Wink et al.
CANCER LETTERS (2003)
Anticancer antifolates: Current status and future directions.
JJ McGuire
CURRENT PHARMACEUTICAL DESIGN (2003)
Glutamate release promotes growth of malignant gliomas
T Takano et al.
NATURE MEDICINE (2001)
Methotrexate suppresses NF-κB activation through inhibition of IκBα phosphorylation and degradation
S Majumdar et al.
JOURNAL OF IMMUNOLOGY (2001)
Share Paper
